Journals / Tüberküloz ve Toraks / 2013 / Cilt: 61 - Sayı: 1

Associations between TGF-β1 G/A and TNF-α 308 G/A gene polymorphisms with airway resistance in chronic obstructive pulmonary disease

Kronik obstrüktif akciğer hastalığında tgf-β1 g/a ve tnf-α 308 g/a gen polimorfizmleri ile hava yolu direncinin değerlendirilmesi

Pages
1–11
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These results can suggest the lack of association between TNF-α 308 G/A and TGF-β1 800 G/A gene polymorp- hisms with COPD development and airway resistance in Turkish population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ntroduction: Chronic obstructive pulmonary disease (COPD) is an important morbidity and mortality cause all over the world.
📊
Key Findings & Data:Although specific gene region has not been defined in the pathogenesis of COPD, cytokine gene polymorphisms li- ke tumor necrosis factor-alfa (TNF-α) and transforming growth factor-beta1 (TGF-β1) may contribute to the development of COPD.
💡
Conclusion & Impact:Conclusion: These results can suggest the lack of association between TNF-α 308 G/A and TGF-β1 800 G/A gene polymorp- hisms with COPD development and airway resistance in Turkish population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ntroduction: Chronic obstructive pulmonary disease (COPD) is an important morbidity and mortality cause all over the world. Although specific gene region has not been defined in the pathogenesis of COPD, cytokine gene polymorphisms li- ke tumor necrosis factor-alfa (TNF-α) and transforming growth factor-beta1 (TGF-β1) may contribute to the development of COPD. The aim of the present study was to evaluate the associations between airway resistance with TGF-β1 G/A and TNF- α 308 G/A gene polymorphisms in COPD patients. Patients and Methods: 264 subjects were included to the study (Group 1; 75 COPD patients, Group 2; 139 subjects with at least 10 packet year smoking history without airflow obstruction, Group 3; 50 healthy subjects). Pulmonary function tests and body plethysmography to measure airway resistance were performed to the subjects. TGF-β1 800 G/A and TNF-α 308 G/A gene polymorphisms were evaluated. Chi-square, Anova and correlation analysis were used for statistical analysis. Results: There were significant difference among COPD stages in terms of TNF-α 308 G/A polymorphism (p 0.05). TNF-α and TGF-β1 genoty- pes and TNF-α 308 G/A and TGF-β1 800 G/A polymorphisms were not different among study groups. Moreover, no signi- ficant differences betweeen subjects with and without increased airway resistance in terms of TNF-α 308 G/A and TGF-β1 800 G/A polymorphisms were present. Conclusion: These results can suggest the lack of association between TNF-α 308 G/A and TGF-β1 800 G/A gene polymorp- hisms with COPD development and airway resistance in Turkish population.

Özet

Giriş: Kronik obstrüktif akciğer hastalığı (KOAH) tüm dünyada önemli bir mortalite ve morbidite nedenidir. Her ne kadar KOAH için spesifik bir gen bölgesi tanımlanmamış olsa da özellikle inflamatuvar süreçte rol alan tümör nekroz faktörü-al- fa (TNF-α), dönüştürülmüş büyüme faktörü-beta1 (TGF-β1) gibi sitokin genlerine ait bazı polimorfizmlerin KOAH gelişimin- de etkili olabileceği gösterildi. Bu çalışma, KOAH’lı olgularda TGF-β1 G/A ve TNF-α 308 G/A gen polimorfizmleriyle hava yolu direnci artışını değerlendirmek amacıyla yapıldı. Hastalar ve Metod: Çalışmaya toplam 264 olgu dahil edildi (Grup 1; KOAH tanısı almış 75 hasta, Grup 2; en az 10 paket yılı sigara içmiş ancak hava yolu obstrüksiyonu gelişmemiş 139 hasta, Grup 3; sağlıklı 50 birey). Olgulara solunum fonk- siyon testi ve vücut pletismografisiyle hava yolu direnci ölçümü yapıldı. TGF-β1 800 G/A ve TNF-α 308 G/A gen polimor- fizmleri değerlendirildi. İstatistiksel analiz için ki-kare testi, Anova ve korelasyon analizleri kullanıldı. Bulgular: KOAH olguları evrelerine göre TNF-α 308 G/A polimorfizm açısından karşılaştırıldığında istatistiksel olarak an- lamlı fark bulundu (p 0.05). Gruplar arasında TNF-α genotipi ve TGF-β1 genotipi ve TNF-α 308 G/A ve TGF-β1 800 G/A polimorfizm sıklığı açısından farklılık saptanmadı. Ayrıca, hava yolu direnci artmış ve artmamış olgular arasında da TNF-α 308 G/A ve TGF-β1 800 G/A polimorfizmi açısından anlamlı fark bulunmadı. Sonuç: Bu sonuçlar ile TNF-α 308 G/A ve TGF-β1 800 G/A polimorfizmlerinin toplumumuzda KOAH gelişimine ve hava yo- lu direncine katkısının önemli derecede olmadığı öngörülebilir.

🔖

Cite This Article

VERDİ, H., ATAÇ, B., ULAŞLI, S. S., ULUBAY, G., MELEK, K., EYÜBOĞLU, F. Ö. (2022). Associations between TGF-β1 G/A and TNF-α 308 G/A gene polymorphisms with airway resistance in chronic obstructive pulmonary disease. Tüberküloz ve Toraks, Cilt: 61 - Sayı: 1, 1–11. https://ajindex.com/articles/618655

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Mathers CD, Loncar D. Projections of global mortality and bur- den of disease from 2002 to 2030. PLoS Med 2006; 3: e442
  2. Petty TL. Chronic obstructive pulmonary disease. In: Hanley ME, Welsh CH (eds). Current Diagnosis and Treatment in Pul- monary Medicine Lange Medical Boks. MacGraw-Hill Compa- nies, 2003: 82-91
  3. Stanford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1380- 91
  4. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pul- monary disease: molecular and cellular mechanisms. Eur Res- pir J 2003; 22: 672-88
  5. Zhang S, Wang C, Xi B, Li X. Association between the tumour necrosis factor-α -308 G/A polymorphism and chronic obst- ructive pulmonary disease: an update. Respirology 2011; 16: 107-15. 6.Gong Y, Fan L, Wan H, Shi Y, Shi G, Feng Y, et al. Lack of as- sociation between the TGF-β(1) gene and development of COPD in Asians: a case-control study and meta-analysis. Lung 2011; 189: 213-23. 7.Kaminsky DA. Spirometry and related tests. In: Ruppel GL (ed). Manual of Pulmonary Function Testing. 9th ed. Chapter 2, Mosby Elsevier, 2009: 36-89
  6. Global Initiative for chronic obstructive pulmonary disease updated, chapter 1 (definition), 2007: 2-6
  7. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casa- buri R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68
  8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Co- ates A, et al; ATS/ERS Task Force. Standardisation of spiro- metry. Eur Respir J 2005; 26: 319-38. 11.Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, et al. Physiological principles of normal lung functi- on. In: Fishman AP (ed). Fishman’s Pulmonary Diseases and Disorders. 4th ed. Vol. I. China: Mc Graw Hill Companies, 2008: 147-60. 12.DuBois AB. Significance of measurement of airway resistance. In: International Symposium on Body Plethysmography, Nij- megen, the Netherlands, 1968. Vol
  9. Progr Res Basel, Swit- zerland: Karger, Res 1969: 109-15. 13.Matthys H, Orth U. Comparative measurements of airway re- sistance. Respiration 1975; 32: 121-34. 14.Murray CJL, Lopez AD. Global health statistics: a compendi- um of incidence, prevalence and mortality estimates for over 200 conditions. Geneva, Switzerland: World Health Organiza- tion, 1996. 15.Kocabaş, A, Hancıoğlu A, Türkyılmaz S, Ünalan T, Umut S, Çakır B, et al. Prevelance of COPD in Adana, Turkey (BOLD- Turkey Study). Proceedings of the Americ